Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells

[1]  S. Dooley,et al.  Glypican-3 promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through ERK signaling pathway. , 2015, International journal of oncology.

[2]  Jia Su,et al.  Silencing of the glypican-3 gene affects the biological behavior of human hepatocellular carcinoma cells. , 2014, Molecular medicine reports.

[3]  Paula Rahal,et al.  GPC3 reduces cell proliferation in renal carcinoma cell lines , 2014, BMC Cancer.

[4]  Xudong Tang,et al.  Dracorhodin perchlorate induces apoptosis in primary fibroblasts from human skin hypertrophic scars via participation of caspase-3. , 2014, European journal of pharmacology.

[5]  S. Bao,et al.  MicroRNA‐520c‐3p inhibits hepatocellular carcinoma cell proliferation and invasion through induction of cell apoptosis by targeting glypican‐3 , 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

[6]  Y. Yen,et al.  Dovitinib synergizes with oxaliplatin in suppressing cell proliferation and inducing apoptosis in colorectal cancer cells regardless of RAS-RAF mutation status , 2014, Molecular Cancer.

[7]  Yan Ma,et al.  Antitumor Activities of Rauwolfia vomitoria Extract and Potentiation of Carboplatin Effects Against Ovarian Cancer☆ , 2013, Current therapeutic research, clinical and experimental.

[8]  C. Landen,et al.  Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation. , 2013, Experimental cell research.

[9]  Zhijian Pan,et al.  Overexpression of GPC3 inhibits hepatocellular carcinoma cell proliferation and invasion through induction of apoptosis. , 2013, Molecular medicine reports.

[10]  Ning Li,et al.  Glypican-3 as a potential differential diagnosis marker for hepatocellular carcinoma: a tissue microarray-based study. , 2012, Acta histochemica.

[11]  R. Zheng,et al.  Enhanced apoptosis of ovarian cancer cells via nanocarrier-mediated codelivery of siRNA and doxorubicin , 2012, International journal of nanomedicine.

[12]  Yi-jun Wang,et al.  Differential diagnostic value of GPC3-CD34 combined staining in small liver nodules with diameter less than 3 cm. , 2012, American journal of clinical pathology.

[13]  P. Heldin,et al.  Hyaluronan Synthase 2 (HAS2) Promotes Breast Cancer Cell Invasion by Suppression of Tissue Metalloproteinase Inhibitor 1 (TIMP-1)* , 2011, The Journal of Biological Chemistry.

[14]  Sung-Wuk Jang,et al.  Human Leucine Zipper Protein sLZIP Induces Migration and Invasion of Cervical Cancer Cells via Expression of Matrix Metalloproteinase-9* , 2011, The Journal of Biological Chemistry.

[15]  P. Zhao,et al.  Inhibition of glypican-3 expression via RNA interference influences the growth and invasive ability of the MHCC97-H human hepatocellular carcinoma cell line. , 2011, International journal of molecular medicine.

[16]  H. Seol,et al.  Role of the cofilin activity cycle in astrocytoma migration and invasion. , 2011, Genes & cancer.

[17]  Fang Wen,et al.  Tanshinone IIA acts via p38 MAPK to induce apoptosis and the down-regulation of ERCC1 and lung-resistance protein in cisplatin-resistant ovarian cancer cells. , 2011, Oncology reports.

[18]  H. Kajiyama,et al.  Growth-suppressing function of glypican-3 (GPC3) via insulin like growth factor II (IGF-II) signaling pathway in ovarian clear cell carcinoma cells. , 2010, Gynecologic oncology.

[19]  H. Kajiyama,et al.  Glypican-3 expression predicts poor clinical outcome of patients with early-stage clear cell carcinoma of the ovary , 2010, Journal of Clinical Pathology.

[20]  Ximing J. Yang,et al.  Glypican 3 has a higher sensitivity than alpha‐fetoprotein for testicular and ovarian yolk sac tumour: immunohistochemical investigation with analysis of histological growth patterns , 2010, Histopathology.

[21]  Masamichi Sugimoto,et al.  Histopathological analyses of the antitumor activity of anti-glypican-3 antibody (GC33) in human liver cancer xenograft models: The essential role of macrophages , 2009 .

[22]  Masamichi Sugimoto,et al.  Histopathological analyses of the antitumor activity of anti-glypican-3 antibody (GC33) in human liver cancer xenograft models: The contribution of macrophages. , 2009, Cancer biology & therapy.

[23]  H. Aburatani,et al.  Anti-glypican 3 antibody as a potential antitumor agent for human liver cancer. , 2008, Cancer research.

[24]  Ximing J. Yang,et al.  Expression of glypican 3 in ovarian and extragonadal germ cell tumors. , 2008, American journal of clinical pathology.

[25]  C. Sturgis,et al.  Transforming Growth Factor-β1, Transforming Growth Factor-β2, and Transforming Growth Factor-β3 Enhance Ovarian Cancer Metastatic Potential by Inducing a Smad3-Dependent Epithelial-to-Mesenchymal Transition , 2008, Molecular Cancer Research.

[26]  S. Thorgeirsson,et al.  Sulfatase 2 up‐regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma , 2008, Hepatology.

[27]  T. Longacre,et al.  Oncofetal Protein Glypican-3 Distinguishes Yolk Sac Tumor From Clear Cell Carcinoma of the Ovary , 2008, The American journal of surgical pathology.

[28]  Peng Jiang,et al.  RFRCDB-siRNA: Improved design of siRNAs by random forest regression model coupled with database searching , 2007, Comput. Methods Programs Biomed..

[29]  H. Moch,et al.  Glypican-3 Expression in Primary and Recurrent Ovarian Carcinomas , 2007, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[30]  D. Sinnett,et al.  In vivo footprinting analysis of the Glypican 3 (GPC3) promoter region in neuroblastoma cells. , 2007, Biochimica et biophysica acta.

[31]  R. Demir,et al.  Immunolocalizations of VEGF, its receptors flt-1, KDR and TGF-beta's in epithelial ovarian tumors. , 2006, Histology and histopathology.

[32]  K. Tsuneyama,et al.  Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. , 2006, Anticancer research.

[33]  J. Yuan,et al.  Overexpression of human KCNA5 increases IK V and enhances apoptosis. , 2004, American journal of physiology. Cell physiology.

[34]  Charles A Powell,et al.  The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor. , 2003, American journal of respiratory cell and molecular biology.

[35]  U. Shankavaram,et al.  Differential Regulation of Lipopolysaccharide-Induced Monocyte Matrix Metalloproteinase (MMP)-1 and MMP-9 by p38 and Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein Kinases , 2003, The Journal of Immunology.

[36]  J. Filmus,et al.  Glypican-3 expression is silenced in human breast cancer , 2001, Oncogene.

[37]  S. Selleck,et al.  Glypicans: proteoglycans with a surprise. , 2001, The Journal of clinical investigation.

[38]  D. Schlessinger,et al.  Frequent silencing of the GPC3 gene in ovarian cancer cell lines. , 1999, Cancer research.

[39]  J. Testa,et al.  OCI-5/GPC3, a Glypican Encoded by a Gene That Is Mutated in the Simpson-Golabi-Behmel Overgrowth Syndrome, Induces Apoptosis in a Cell Line–specific Manner , 1998, The Journal of cell biology.

[40]  A. Passaniti,et al.  Stimulation of human prostatic carcinoma tumor growth in athymic mice and control of migration in culture by extracellular matrix , 1992, International journal of cancer.